164 related articles for article (PubMed ID: 7606796)
1. A synthetic peptide corresponding to a critical intracellular signaling region of the human IL-4 receptor inhibits IL-4-induced proliferation.
Izuhara K; Sakai M; Inaba R; Imamura T; Howard M; Harada N
Cell Immunol; 1995 Jul; 163(2):254-9. PubMed ID: 7606796
[TBL] [Abstract][Full Text] [Related]
2. The chimeric receptor between interleukin-2 receptor beta chain and interleukin-4 receptor transduces interleukin-2 signal.
Izuhara K; Miyajima A; Harada N
Biochem Biophys Res Commun; 1993 Feb; 190(3):992-1000. PubMed ID: 7679903
[TBL] [Abstract][Full Text] [Related]
3. Human interleukin-4 receptor signaling requires sequences contained within two cytoplasmic regions.
Koettnitz K; Kalthoff FS
Eur J Immunol; 1993 Apr; 23(4):988-91. PubMed ID: 8458387
[TBL] [Abstract][Full Text] [Related]
4. Function of the human interleukin 4 receptor (IL-4R)-derived acidic motif revealed by cytoplasmic domain chimeras of the IL-4R alpha chain and the IL-2R beta chain.
Deutsch HH; Chung J; Kalthoff FS
Cytokine; 1998 May; 10(5):331-6. PubMed ID: 9619370
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation.
Nelson BH; Lord JD; Greenberg PD
Nature; 1994 May; 369(6478):333-6. PubMed ID: 7514277
[TBL] [Abstract][Full Text] [Related]
6. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-4 activates two distinct pathways of phosphatidylinositol-3 kinase in the same cells.
Izuhara K; Harada N
Biochem Biophys Res Commun; 1996 Dec; 229(2):624-9. PubMed ID: 8954948
[TBL] [Abstract][Full Text] [Related]
8. Expression cloning and characterization of a human IL-10 receptor.
Liu Y; Wei SH; Ho AS; de Waal Malefyt R; Moore KW
J Immunol; 1994 Feb; 152(4):1821-9. PubMed ID: 8120391
[TBL] [Abstract][Full Text] [Related]
9. The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor.
Liu Y; de Waal Malefyt R; Briere F; Parham C; Bridon JM; Banchereau J; Moore KW; Xu J
J Immunol; 1997 Jan; 158(2):604-13. PubMed ID: 8992974
[TBL] [Abstract][Full Text] [Related]
10. The critical region in the cytoplasmic domain of human IL-4 receptor for induction of IgE synthesis.
Schultz C; Izuhara K; Coffman R; Harada N
Immunol Lett; 1995 Jun; 46(3):215-9. PubMed ID: 7590938
[TBL] [Abstract][Full Text] [Related]
11. Selective expansion of genetically modified T cells using an antibody/interleukin-2 receptor chimera.
Sogo T; Kawahara M; Tsumoto K; Kumagai I; Ueda H; Nagamune T
J Immunol Methods; 2008 Aug; 337(1):16-23. PubMed ID: 18589435
[TBL] [Abstract][Full Text] [Related]
12. Synthetic peptides mapping to epitopes of the extracellular domain of the interleukin-2 receptor beta-chain to inhibit T-cell activation.
Parissi T; Chatzantoni K; Deraos S; Matsoukas I; Mouzaki A
Transplant Proc; 2004; 36(6):1723-7. PubMed ID: 15350462
[TBL] [Abstract][Full Text] [Related]
13. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
[TBL] [Abstract][Full Text] [Related]
14. Characterization of critical residues in the cytoplasmic domain of the human interleukin-5 receptor alpha chain required for growth signal transduction.
Cornelis S; Fache I; Van der Heyden J; Guisez Y; Tavernier J; Devos R; Fiers W; Plaetinck G
Eur J Immunol; 1995 Jul; 25(7):1857-64. PubMed ID: 7542592
[TBL] [Abstract][Full Text] [Related]
15. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
[TBL] [Abstract][Full Text] [Related]
16. Murine IL-4 is able to signal via chimeric human IL-4Ralpha/mouse gamma-chain receptor.
Myburgh E; Horsnell WG; Cutler AJ; Arendse B; Kubo M; Brombacher F
Mol Immunol; 2008 Mar; 45(5):1327-36. PubMed ID: 18029018
[TBL] [Abstract][Full Text] [Related]
17. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
Rahaman SO; Sharma P; Harbor PC; Aman MJ; Vogelbaum MA; Haque SJ
Cancer Res; 2002 Feb; 62(4):1103-9. PubMed ID: 11861389
[TBL] [Abstract][Full Text] [Related]
18. Regulation of interleukin-2 and interleukin-4 receptor expression in human and ape lymphoid cell lines.
Guizani L; Lang P; Stancou R; Bertoglio J
Lymphokine Cytokine Res; 1993 Feb; 12(1):25-32. PubMed ID: 8457629
[TBL] [Abstract][Full Text] [Related]
19. IL-4-dependent proliferation of BA/F3 cells expressing a growth-negative mutant of the human IL-4 receptor is restored by enforced expression of Bcl-2.
Chung J; Deutsch HH; Kalthoff FS
J Leukoc Biol; 1996 Apr; 59(4):586-90. PubMed ID: 8613708
[TBL] [Abstract][Full Text] [Related]
20. Ligand-dependent activation of chimeric receptors with the cytoplasmic domain of the interleukin-3 receptor beta subunit (beta IL3).
Sakamaki K; Wang HM; Miyajima I; Kitamura T; Todokoro K; Harada N; Miyajima A
J Biol Chem; 1993 Jul; 268(21):15833-9. PubMed ID: 8340408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
